EN
HI
Summary
As of 11 Nov, 2026, Accretion Nutraveda stock price is ₹350. During the trading session, the stock has moved between an intraday low of ₹350.00 and an intraday high of ₹350.00. Over the last 52 weeks, Accretion Nutraveda has traded between ₹150.10 and ₹350.00.
The stock has recorded a trading volume of 1,000 shares,. Its Average Traded Price (ATP) is ₹350.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1000 @ ₹350.00.
Accretion Nutraveda has an upper circuit limit of ₹397.20 and a lower circuit limit of ₹264.80. The total value traded stands at ₹3.50 L, and the delivery percentage for the day is -1%.
The stock is currently traded with a market lot size of 1000. Accretion Nutraveda also offers a dividend yield of 0%.
Accretion Nutraveda Share Price Chart
Accretion Nutraveda Share Key Metrics
Volume
1000.00
Market Cap
239.64 CR
LTQ@LTP
1000@350.00
ATP
350
Var Margin
53.5 %
Circuit Range
264.8-397.2
Delivery %
- %
Value
3.50 L
ASM/GSM
No
Market Lot
1000
Accretion Nutraveda Resistance and Support
Pivot 331
Resistance
First Resistance
331
Second Resistance
331
Third Resistance
331
Support
First Support
331
Second Support
331
Third Support
331
Accretion Nutraveda Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Nov 11 2026 | 350 | 350 | 5.74% | 350 | 350 |
| Sun Nov 08 2026 | 331 | 331 | 0.61% | 331 | 331 |
| Fri Nov 06 2026 | 305 | 329 | 5.79% | 333 | 305 |
Accretion Nutraveda Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-31 | Half Yearly Results |
| 2026-05-08 | Audited Results |
Accretion Nutraveda News
Accretion Nutraveda Ltd - 544694 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Accretion Nutraveda announced its H1 FY27 results, reporting a 109.35% YoY increase in revenue to Rs.29.44 crores. Net profit grew by 98.66% YoY to Rs.4.73 crores, supported by higher sales volumes and better cost management.
Oct 31 2026 19:26:20
Accretion Nutraveda Ltd - 544694 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 31St October, 2026
Accretion Nutraveda reported H1 FY27 revenue of ₹29.44 crores, representing a 109% YoY growth. Net profit for the period increased by 99% YoY to ₹4.73 crores. The company also disclosed IPO proceeds utilization of ₹18.21 crores.
Oct 31 2026 19:15:52
Read More
Accretion Nutraveda Management
| Name | Position |
|---|---|
| Mayur Popatlal Sojitra | Managing Director |
| Ankurkumar Patel | Whole Time Director |
Accretion Nutraveda FAQs
The Buying Price of Accretion Nutraveda share is 350 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Accretion Nutraveda stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Accretion Nutraveda, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Accretion Nutraveda shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Accretion Nutraveda shares is 0. Useful to assess the stock's value relative to its book value.
To assess Accretion Nutraveda’s valuation compare Sector P/E, P/B which are 40.97 & 3.82 with sector averages, along with growth rates and financial metrics.
The Market Cap of Accretion Nutraveda is 239.64 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Accretion Nutraveda share price is 350.00 & 150.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Accretion Nutraveda belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ANL
